Lack of Benefit of Iron Chelation in Early Parkinson's Disease
N Engl J Med
.
2022 Dec 1;387(22):2087-2088.
doi: 10.1056/NEJMe2213120.
Authors
Douglas Galasko
1
,
Tanya Simuni
1
Affiliation
1
From the Department of Neurosciences, University of California, San Diego, La Jolla (D.G.); and the Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago (T.S.).
PMID:
36449427
DOI:
10.1056/NEJMe2213120
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Iron Chelating Agents* / adverse effects
Iron Chelating Agents* / therapeutic use
Parkinson Disease* / complications
Parkinson Disease* / drug therapy
Substances
Iron Chelating Agents